Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
100%(7 trials)

Phase Distribution

Ph phase_1
5
63%
Ph phase_3
3
38%

Phase Distribution

5

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
5(62.5%)
Phase 3Large-scale testing
3(37.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

87.5%

7 of 8 finished

Non-Completion Rate

12.5%

1 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Terminated(1)

Detailed Status

Completed7
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 15 (62.5%)
Phase 33 (37.5%)

Trials by Status

completed788%
withdrawn113%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_3

A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes

NCT02132637
completedphase_3

A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment

NCT01894568
completedphase_1

A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes

NCT01771250
completedphase_1

A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue

NCT02109029
completedphase_1

A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements

NCT02152384
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT02132637Phase 3

A Study to Compare the Effect of a Double Dose of Two Long-acting Insulin Therapies in Participants With Type 2 Diabetes

Completed
NCT01894568Phase 3

A Study Comparing Insulin Peglispro With Insulin Glargine as Basal Insulin Treatment

Completed
NCT01771250Phase 1

A Study of Insulin Peglispro and Glargine on Fats in Participants With Type 1 Diabetes

Completed
NCT02109029Phase 1

A Study of LY2605541 (Insulin Peglispro) and Human Insulin Concentrations in Fat Tissue

Completed
NCT02152384Phase 1

A Study to Compare and Measure the Effects of Insulin Peglispro (LY2605541) and Glargine on Meal Time Insulin Requirements

Completed
NCT02197520Phase 1

A Study To Compare the Effects of Insulin Peglispro and Glargine on Insulin Sensitivity and Meal Time Insulin Requirements in Type 2 Diabetics

Completed
NCT01995526Phase 1

A Study of Insulin Peglispro in Healthy Male Japanese Participants

Completed
NCT02106364Phase 3

A Study of Insulin Peglispro (LY2605541) in Participants With Type 2 Diabetes Mellitus

Withdrawn

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8